1. Home
  2. AZN
  3. AZN News

Latest AstraZeneca PLC (AZN) News on August 6, 2025

AZN

PR Newswire

4 hours ago

Compugen Reports Second Quarter 2025 Results

AZN

MT Newswires

5 hours ago

US Health Department Ending Federal mRNA Vaccine Development

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines
AZN

GlobeNewswire

7 hours ago

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

Trump says pharma tariffs to start small, then soar to 250%
AZN

Reuters Videos

12 hours ago

Trump says pharma tariffs to start small, then soar to 250%

Trump threatens 250pc tariffs on drug imports
AZN

The Telegraph

a day ago

Trump threatens 250pc tariffs on drug imports

AZN

MT Newswires

a day ago

SOPHiA GENETICS Expanding Collaboration With AstraZeneca Focused on Breast Cancer

EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
AZN

Benzinga

a day ago

EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
AZN

PR Newswire

a day ago

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
AZN

GlobeNewswire

2 days ago

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
AZN

Zacks

2 days ago

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
AZN

GlobeNewswire

2 days ago

AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
AZN

The Wall Street Journal

3 days ago

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals
AZN

CNN Business

4 days ago

Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals

AstraZeneca Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
AZN

Simply Wall St.

4 days ago

AstraZeneca Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Health Care Roundup: Market Talk
AZN

The Wall Street Journal

5 days ago

Health Care Roundup: Market Talk

Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
AZN

Zacks

5 days ago

Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
AZN

Zacks

5 days ago

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
AZN

Zacks

5 days ago

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
AZN

The Wall Street Journal

5 days ago

Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck
AZN

The Wall Street Journal

5 days ago

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck

AZN

MT Newswires

5 days ago

Pharma Stocks Fall Pre-Bell After Trump's Letters to Companies Over Drug Pricing

Stocks to Watch Friday: Apple, Amazon, Coinbase, Reddit
AZN

The Wall Street Journal

5 days ago

Stocks to Watch Friday: Apple, Amazon, Coinbase, Reddit

European drugmakers fall after Trump raises stakes over US drug price cuts
AZN

Reuters

5 days ago

European drugmakers fall after Trump raises stakes over US drug price cuts

Trump doubles down on Most Favored Nation plan to target drug prices
AZN

Pharmaceutical Technology

6 days ago

Trump doubles down on Most Favored Nation plan to target drug prices

What Trump's Big Pharma CEO letters mean for drug pricing power
AZN

Yahoo Finance Video

6 days ago

What Trump's Big Pharma CEO letters mean for drug pricing power

AstraZeneca Just Missed Estimates, but Here’s Why Bulls Aren’t Worried Yet
AZN

Insider Monkey

7 days ago

AstraZeneca Just Missed Estimates, but Here’s Why Bulls Aren’t Worried Yet

US Expansion Not Driven By Tariffs: AstraZeneca CFO
AZN

Bloomberg

8 days ago

US Expansion Not Driven By Tariffs: AstraZeneca CFO

AZN

Morningstar Research

8 days ago

Analyst Report: AstraZeneca PLC

Why AstraZeneca Stock Was Topping the Market on Tuesday
AZN

Motley Fool

8 days ago

Why AstraZeneca Stock Was Topping the Market on Tuesday

AstraZeneca Profit, Revenue Lifted by Cancer Drugs
AZN

Bloomberg

8 days ago

AstraZeneca Profit, Revenue Lifted by Cancer Drugs

Pharma tariffs would be 'counterproductive,' industry rep. says
AZN

Yahoo Finance Video

8 days ago

Pharma tariffs would be 'counterproductive,' industry rep. says

AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO
AZN

Yahoo Finance

8 days ago

AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO

IonQ (IONQ) Names Quantum Pioneer Marco Pistoia As Senior Vice President
AZN

Simply Wall St.

8 days ago

IonQ (IONQ) Names Quantum Pioneer Marco Pistoia As Senior Vice President

AZN

MT Newswires

8 days ago

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

European stocks rally with eyes on earnings, trade deal
AZN

AFP

8 days ago

European stocks rally with eyes on earnings, trade deal

AstraZeneca results: H1 and Q2 2025
AZN

Business Wire

8 days ago

AstraZeneca results: H1 and Q2 2025

Health Care Roundup: Market Talk
AZN

The Wall Street Journal

8 days ago

Health Care Roundup: Market Talk

AstraZeneca beats profit forecasts on strong sales and U.S. demand
AZN

Reuters Videos

8 days ago

AstraZeneca beats profit forecasts on strong sales and U.S. demand

AZN

Associated Press Finance

8 days ago

Astrazeneca: Q2 Earnings Snapshot

AZN

MT Newswires

8 days ago

Astrazeneca Q2 Core Earnings, Revenue Rise; 2025 Guidance Maintained

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth
AZN

The Wall Street Journal

8 days ago

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth

AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
AZN

GlobeNewswire

9 days ago

AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

IMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers
AZN

Business Wire

9 days ago

IMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers

AZN

MT Newswires

9 days ago

AstraZeneca's Imfinzi Granted FDA Priority Review for Early-Stage Gastric Cancers

Synthetic rescue: Insmed explores a new frontier in genetic therapeutics
AZN

Pharmaceutical Technology

9 days ago

Synthetic rescue: Insmed explores a new frontier in genetic therapeutics

3 UK Stocks Estimated To Be Up To 47.5% Below Intrinsic Value
AZN

Simply Wall St.

9 days ago

3 UK Stocks Estimated To Be Up To 47.5% Below Intrinsic Value

Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results
AZN

PR Newswire

10 days ago

Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built on Innovation
AZN

Insider Monkey

11 days ago

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built on Innovation

Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors
AZN

Zacks

12 days ago

Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors

AstraZeneca (LSE:AZN) Showcases Promising Results For Gefurulimab In Global Myasthenia Gravis Study
AZN

Simply Wall St.

12 days ago

AstraZeneca (LSE:AZN) Showcases Promising Results For Gefurulimab In Global Myasthenia Gravis Study

AZN

MT Newswires

12 days ago

AstraZeneca's Pressurized Inhaler With Low-Carbon Propellant Wins EU Support

AZN

MT Newswires

12 days ago

Bristol-Myers Squibb Names Cristian Massacesi as Chief Medical Officer

Bristol Myers shuffles its executive ranks with new CMO
AZN

BioPharma Dive

12 days ago

Bristol Myers shuffles its executive ranks with new CMO

gMG race hots up as AstraZeneca’s star candidate meets Phase III targets
AZN

Clinical Trials Arena

13 days ago

gMG race hots up as AstraZeneca’s star candidate meets Phase III targets

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
AZN

Benzinga

13 days ago

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

Selective Estrogen Receptor Degrader (SERDs) Market Research Report 2025-2030 Featuring AstraZeneca, Eli Lilly, EnhancedBio, Olema Oncology, Radius Therapeutics, and Roche
AZN

GlobeNewswire

13 days ago

Selective Estrogen Receptor Degrader (SERDs) Market Research Report 2025-2030 Featuring AstraZeneca, Eli Lilly, EnhancedBio, Olema Oncology, Radius Therapeutics, and Roche

AZN

MT Newswires

13 days ago

Sector Update: Health Care Stocks Mixed Premarket Thursday

Insights Into Astrazeneca (AZN) Q2: Wall Street Projections for Key Metrics
AZN

Zacks

13 days ago

Insights Into Astrazeneca (AZN) Q2: Wall Street Projections for Key Metrics

AZN

MT Newswires

13 days ago

AstraZeneca Says Gefurulimab Reduces Generalized Myasthenia Gravis Severity in Phase 3 Trial

LUNGevity Foundation Joins 2025 LungXperience Tour to Promote Lung Health and Early Detection Across the U.S.
AZN

PR Newswire

13 days ago

LUNGevity Foundation Joins 2025 LungXperience Tour to Promote Lung Health and Early Detection Across the U.S.

AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial
AZN

BioPharma Dive

13 days ago

AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial

AZN

Morningstar Research

14 days ago

Analyst Report: AstraZeneca PLC

AstraZeneca (LSE:AZN) Commits US$50 Billion For US Expansion By 2030
AZN

Simply Wall St.

14 days ago

AstraZeneca (LSE:AZN) Commits US$50 Billion For US Expansion By 2030

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports
AZN

GlobeNewswire

14 days ago

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports

AstraZeneca announces $50bn US investment plans by 2030
AZN

Pharmaceutical Technology

14 days ago

AstraZeneca announces $50bn US investment plans by 2030

Trump Announces Japan Trade Pact, Revises Trade Terms With Indonesia, Philippines
AZN

Barrons.com

15 days ago

Trump Announces Japan Trade Pact, Revises Trade Terms With Indonesia, Philippines

AstraZeneca Announces $50B US Investment Amid Pharma Tariff Threat
AZN

GuruFocus.com

15 days ago

AstraZeneca Announces $50B US Investment Amid Pharma Tariff Threat

S&P 500 Notches New Record, Nasdaq Snaps 6-Day Winning Streak
AZN

MT Newswires

15 days ago

S&P 500 Notches New Record, Nasdaq Snaps 6-Day Winning Streak

China innovation and deals are good for biotech: AstraZeneca CEO
AZN

Yahoo Finance

15 days ago

China innovation and deals are good for biotech: AstraZeneca CEO

Pharma sector outlook as Trump's drug tariff deadline looms
AZN

Yahoo Finance Video

15 days ago

Pharma sector outlook as Trump's drug tariff deadline looms

AZN

MT Newswires

15 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

Corporate Earnings, Trade Developments Leave Equity Markets Mixed Intraday
AZN

MT Newswires

15 days ago

Corporate Earnings, Trade Developments Leave Equity Markets Mixed Intraday

Lockheed Martin, AstraZeneca, DR Horton: Trending Tickers
AZN

Yahoo Finance Video

15 days ago

Lockheed Martin, AstraZeneca, DR Horton: Trending Tickers

AstraZeneca to invest $50 bn in the US as tariff threat looms
AZN

AFP

15 days ago

AstraZeneca to invest $50 bn in the US as tariff threat looms

Trade News: Pharma Invests in U.S. to Counter Tariffs, Jeep Maker Swings to Loss
AZN

Barrons.com

15 days ago

Trade News: Pharma Invests in U.S. to Counter Tariffs, Jeep Maker Swings to Loss

Astrazeneca, Phillip Morris & D.R. Horton earnings: Trending Tickers
AZN

Yahoo Finance Video

15 days ago

Astrazeneca, Phillip Morris & D.R. Horton earnings: Trending Tickers

5 Things to Know Before the Stock Market Opens
AZN

Investopedia

15 days ago

5 Things to Know Before the Stock Market Opens

Stocks Down Pre-Bell Ahead of Key Earnings, Fed Chair Powell's Speech
AZN

MT Newswires

15 days ago

Stocks Down Pre-Bell Ahead of Key Earnings, Fed Chair Powell's Speech

Leptomeningeal Metastases Market Research Report 2025-2035 | Competitive Analysis of Plus Therapeutics, AstraZeneca, AngioChem, and Y-mAbs Therapeutics
AZN

GlobeNewswire

15 days ago

Leptomeningeal Metastases Market Research Report 2025-2035 | Competitive Analysis of Plus Therapeutics, AstraZeneca, AngioChem, and Y-mAbs Therapeutics

AstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030
AZN

Investopedia

15 days ago

AstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030

Xelix secures $160 million Series B to advance agentic AI innovation in Accounts Payable
AZN

PR Newswire

16 days ago

Xelix secures $160 million Series B to advance agentic AI innovation in Accounts Payable

AZN

MT Newswires

16 days ago

AstraZeneca's Tagrisso-Chemo Combination Hits Key Secondary Endpoint in Lung Cancer Study

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer
AZN

Business Wire

16 days ago

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer

UK Stocks That Might Be Trading Below Their Estimated Value
AZN

Simply Wall St.

16 days ago

UK Stocks That Might Be Trading Below Their Estimated Value

Is AstraZeneca (AZN) a Reliable Dividend Stock for Long-Term Investors?
AZN

Insider Monkey

19 days ago

Is AstraZeneca (AZN) a Reliable Dividend Stock for Long-Term Investors?

AstraZeneca announces Enhertu combination with pertuzumab granted BTD by FDA
AZN

TipRanks

19 days ago

AstraZeneca announces Enhertu combination with pertuzumab granted BTD by FDA

UK Stocks Priced Below Estimated Fair Value In July 2025
AZN

Simply Wall St.

19 days ago

UK Stocks Priced Below Estimated Fair Value In July 2025

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
AZN

Zacks

20 days ago

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings
AZN

Insider Monkey

20 days ago

Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings

TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
AZN

Zacks

20 days ago

TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?

AstraZeneca (LSE:AZN) Anselamimab Shows Promise In AL Amyloidosis Despite Missing Main Endpoint
AZN

Simply Wall St.

20 days ago

AstraZeneca (LSE:AZN) Anselamimab Shows Promise In AL Amyloidosis Despite Missing Main Endpoint

AstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage Studies
AZN

Zacks

20 days ago

AstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage Studies

AZN

MT Newswires

20 days ago

AstraZeneca, Daiichi Sankyo Win FDA Breakthrough Therapy Designation for Breast Cancer Drug

ENHERTU® Plus Pertuzumab Granted Breakthrough Therapy Designation in the U.S. as First-Line Therapy for Patients with HER2 Positive Metastatic Breast Cancer
AZN

Business Wire

20 days ago

ENHERTU® Plus Pertuzumab Granted Breakthrough Therapy Designation in the U.S. as First-Line Therapy for Patients with HER2 Positive Metastatic Breast Cancer

AstraZeneca’s AL amyloidosis drug fails to impress in Phase III
AZN

Clinical Trials Arena

20 days ago

AstraZeneca’s AL amyloidosis drug fails to impress in Phase III

AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition
AZN

Benzinga

21 days ago

AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition

Trump threatens tariffs on medicines within weeks
AZN

The Telegraph

21 days ago

Trump threatens tariffs on medicines within weeks

Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda
AZN

PR Newswire

21 days ago

Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda

AZN

MT Newswires

21 days ago

Astrazeneca's Anselamimab Misses Primary Goal in Phase III Amyloidosis Trial, Shares Down

AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study
AZN

Reuters

21 days ago

AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study

Share on Social Networks: